In Treatment for Renal Cell (Kidney) Cancer

Explore the latest clinical outcomes for Cabometyx in treating advanced kidney cancer. Learn about survival rates, efficacy, and combination therapy results.

Wondering how long you stay on immunotherapy for kidney cancer? Learn about treatment duration, cycles, and stopping criteria in our 2026 patient guide.

Understand the differences between partial and radical nephrectomy. Learn how your surgical choice impacts long-term kidney function and recovery outcomes.

Understand the differences between Type 1 and Type 2 papillary renal cell carcinoma. Learn why subtype identification is vital for effective treatment planning.

Learn about immune-related side effects in kidney cancer combination therapy. Understand risks, nephrotoxicity, and how to protect kidney function during treatment.

For people with advanced clear-cell renal cell carcinoma (ccRCC), treatment decisions can become more complicated when cancer progresses after immunotherapy. Immune checkpoint inhibitors have transformed care for many people with kidney cancer. Until now, there has been an important unanswered question: What is the best treatment option when the cancer starts growing again after immunotherapy? […]

Learn how combination immunotherapy for kidney cancer works and how to identify and manage potential immune-related side effects during your treatment journey.

For people with advanced clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, researchers are continuing to look for new treatments, especially for cancer that has stopped responding to standard therapies. One potential new option is casdatifan, a treatment designed to block a protein called hypoxia-inducible factor 2-alpha (HIF-2α). Early results […]

Learn what to expect during Cabometyx treatment for advanced renal cell carcinoma. Discover tips for managing side effects, diet, and tracking your progress.

Understand clear cell renal cell carcinoma treatment options. Learn about staging, nephrectomy procedures, and how to build a personalized roadmap for care.

At the 2026 ASCO Genitourinary Cancers Symposium, new studies highlighted advances in renal cell (kidney) cancer treatment. There were exciting updates on novel combinations of immunotherapy and targeted therapies that can provide more treatment options for patients. Below are some of the top headlines. A potential new standard option for high-risk patients with clear cell […]

Immunotherapy has transformed treatment for advanced renal cell (kidney) cancer, but for many patients, it can cause significant side effects that sometimes lead to treatment delays or interruptions. New research is exploring whether improving gut health could make these treatments work better and more safely. In a small early-phase clinical trial, researchers tested whether fecal […]